i-SENS, Inc. engages in the development, manufacture and sales of medical sensors and measuring instruments based on electrochemical and biosensor technologies. It operates through the Blood Glucose Meter and Point-of-Care business divisions. The Blood Glucose Meter business division is composed of a diagnostic device that allows to measure the amount of glucose in the blood and consists of a blood glucose meter, blood glucose strip, and lancet. The Point-of-Care business division consists of diagnostic testing conducted at the patient’s site, rather than in a central laboratory. The company was founded by Geun-Sig Cha and Hak-Hyun Nam on May 4, 2000 and is headquartered in Seoul, South Korea.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company